197 related articles for article (PubMed ID: 29872017)
1. Chlorogenic acid alleviates autophagy and insulin resistance by suppressing JNK pathway in a rat model of nonalcoholic fatty liver disease.
Yan H; Gao YQ; Zhang Y; Wang H; Liu GS; Lei JY
J Biosci; 2018 Jun; 43(2):287-294. PubMed ID: 29872017
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease.
Yan H; Gao Y; Zhang Y
Mol Med Rep; 2017 Jan; 15(1):180-186. PubMed ID: 27909723
[TBL] [Abstract][Full Text] [Related]
3. Mangiferin ameliorates fatty liver via modulation of autophagy and inflammation in high-fat-diet induced mice.
Wang H; Zhu YY; Wang L; Teng T; Zhou M; Wang SG; Tian YZ; Du L; Yin XX; Sun Y
Biomed Pharmacother; 2017 Dec; 96():328-335. PubMed ID: 29024899
[TBL] [Abstract][Full Text] [Related]
4. Hepatoprotective Effect of Loquat Leaf Flavonoids in PM
Jian T; Ding X; Wu Y; Ren B; Li W; Lv H; Chen J
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275422
[TBL] [Abstract][Full Text] [Related]
5. Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK.
Du J; Zhang M; Lu J; Zhang X; Xiong Q; Xu Y; Bao Y; Jia W
Endocrine; 2016 Sep; 53(3):701-9. PubMed ID: 26994931
[TBL] [Abstract][Full Text] [Related]
6. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.
Gan L; Meng ZJ; Xiong RB; Guo JQ; Lu XC; Zheng ZW; Deng YP; Luo BD; Zou F; Li H
Acta Pharmacol Sin; 2015 May; 36(5):597-605. PubMed ID: 25891086
[TBL] [Abstract][Full Text] [Related]
7. Total sesquiterpene glycosides from Loquat (Eriobotrya japonica) leaf alleviate high-fat diet induced non-alcoholic fatty liver disease through cytochrome P450 2E1 inhibition.
Jian T; Ao X; Wu Y; Lv H; Ma L; Zhao L; Tong B; Ren B; Chen J; Li W
Biomed Pharmacother; 2017 Jul; 91():229-237. PubMed ID: 28458161
[TBL] [Abstract][Full Text] [Related]
8. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway.
Wu D; Liu Z; Wang Y; Zhang Q; Li J; Zhong P; Xie Z; Ji A; Li Y
Oxid Med Cell Longev; 2021; 2021():5599997. PubMed ID: 33953830
[TBL] [Abstract][Full Text] [Related]
10. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol protects against hepatic insulin resistance in a rat's model of non-alcoholic fatty liver disease by down-regulation of GPAT-1 and DGAT2 expression and inhibition of PKC membranous translocation.
Badi RM; Mostafa DG; Khaleel EF; Satti HH
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):545-555. PubMed ID: 30773673
[TBL] [Abstract][Full Text] [Related]
12. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
14. Optimization of dosage ratio of chlorogenic acid and gardenia glycosides in the treatment of rats with fatty liver disease induced by high-fat feed.
Liang H; Yang J; Tang J; Wu C; Li H; Chen S
J Tradit Chin Med; 2016 Oct; 36(5):683-8. PubMed ID: 29949319
[TBL] [Abstract][Full Text] [Related]
15. Telmisartan and/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase/sphingoine-1-phosphate pathway, and TLR4 receptors.
Alqarni I; Bassiouni YA; Badr AM; Ali RA
Biochem Pharmacol; 2019 Jun; 164():252-262. PubMed ID: 31004566
[TBL] [Abstract][Full Text] [Related]
16. Tumor Necrosis Factor α-Induced Protein 8-Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta-Activated Kinase 1 Activation.
Liu Y; Song J; Yang J; Zheng J; Yang L; Gao J; Tian S; Liu Z; Meng X; Wang JC; Dai Z; Tang YD
Hepatology; 2021 Sep; 74(3):1300-1318. PubMed ID: 33768585
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
19. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
Elshazly SM
Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756
[TBL] [Abstract][Full Text] [Related]
20. Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity.
Hwang KA; Hwang YJ; Kim GR; Choe JS
BMC Complement Altern Med; 2015 Oct; 15():347. PubMed ID: 26438035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
